Inventor
VENUTI MICHAEL C
US25 patents
⚠️ This page may combine multiple inventors who share the name “VENUTI MICHAEL C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTEX INC
23 patentsUS4761416AAug 2, 1988
N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds
SYNTEX INC33 citations92
US4739056AApr 19, 1988
N-N-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl)oxy-alkylamides and related compounds
SYNTEX INC32 citations92
US4670434AJun 2, 1987
(2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
SYNTEX INC26 citations92
US4593029AJun 3, 1986
Novel ω-(N-imidazolyl)alkyl ethers of 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
SYNTEX INC35 citations92
US4490371ADec 25, 1984
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
SYNTEX INC34 citations92
US4929630AMay 29, 1990
Transglutaminase inhibitors
SYNTEX INC49 citations91
US4912120AMar 27, 1990
3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors
SYNTEX INC55 citations91
US4970297ANov 13, 1990
Transglutaminase inhibitors
SYNTEX INC22 citations81
US4663320AMay 5, 1987
(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
SYNTEX INC22 citations81
US4593120AJun 3, 1986
Naphthalene anti-psoriatic agents
SYNTEX INC7 citations74
US4466981AAug 21, 1984
Naphthalene anti-psoriatic agents
SYNTEX INC14 citations74
US4296042AOct 20, 1981
Preparation of unsaturated aliphatic insect pheromones using cyclic phosphonium ylids
SYNTEX INC7 citations74
US5089657AFeb 18, 1992
Naphthalene anti-psoriatic agents
SYNTEX INC2 citations63
US4786652ANov 22, 1988
Naphthalene anti-psoriatic agents
SYNTEX INC5 citations63
US4758587AJul 19, 1988
Naphthalene anti-psoriatic agents
SYNTEX INC5 citations63
US4690925ASep 1, 1987
(2-Oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl) oxyalkylamides properties having phosphodiosterase inhibiting
SYNTEX INC3 citations63
US5155132AOct 13, 1992
Naphthalene lipoxygenase-inhibiting agents
SYNTEX INC2 citations62
US4551459ANov 5, 1985
Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides
SYNTEX INC4 citations62
US5134161AJul 28, 1992
Method for treating disease states in mammals with naphthalene lipoxygenase-inhibiting agents
SYNTEX INC1 citations52
US4840965AJun 20, 1989
Naphthalene anti-psoriatic agents
SYNTEX INC1 citations52
US4792556ADec 20, 1988
Naphthalene anti-psoriatic agents
SYNTEX INC1 citations45
US5091558AFeb 25, 1992
Naphthalene anti-psoriatic agents
SYNTEX INC0 citations42
US4946845AAug 7, 1990
Naphthalene anti-psoriatic agents
SYNTEX INC0 citations39